Rani Therapeutics Holdings Inc
Rani Therapeutics Holdings Inc (RANI) Options Open Interest
RANI options open interest is 5,153 contracts. The 2-week average daily volume is 82 contracts across the chain.
Read more
Monitoring RANI open interest helps you see where real money is positioned on Rani Therapeutics Holdings Inc's options and which strikes are attracting the most commitment from traders. Rani Therapeutics Holdings Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor RANI options open interest in real time and find the strikes that matter.
Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising RANI options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Rani Therapeutics Holdings Inc to settle.
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-alpha antibody to treat psoriatic arthritis; RT-102, a parathyroid hormone that is in preclinical studies for the treatment of osteoporosis; RT-109, a human growth hormone to treat growth hormone deficiency; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-106, a basal insulin for the treatment of type 2 diabetes.
The company was incorporated in 2012 and is headquartered in San Jose, California.
Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where RANI open interest is concentrated. Our scanner maps Rani Therapeutics Holdings Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Rani Therapeutics Holdings Inc's options open interest as the signal it is, not as an afterthought.
| 1.00 | 0.05 | 0.10 | 0.08 | 132% | +0.4088 | 1,570 |
| 1.50 | — | 0.10 | 0.10 | 264% | +0.3416 | 533 |
| 2.50 | — | 0.05 | 0.05 | 297% | +0.1829 | 216 |
| 0.50 | — | 0.75 | 0.75 | 1,000% | +0.9412 | 109 |
| 2.00 | — | 0.75 | 0.75 | 1,000% | +0.8547 | 21 |
| 0.50 | — | 0.05 | 0.05 | 246% | -0.1255 | 130 |
| 2.00 | 0.80 | 1.70 | 1.25 | 343% | -0.6659 | 30 |
| 1.50 | 0.30 | 1.20 | 0.75 | 280% | -0.6331 | 3 |
| 1.00 | — | 0.75 | 0.75 | 813% | -0.1485 | 0 |
| 2.50 | 1.30 | 2.20 | 1.75 | 388% | -0.6823 | 0 |
As of September 18, 2026
Follow the money
Track RANI open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.
Start your 14-day free trial→